Treatment of cutaneous leishmaniasis with liposomal amphotericin B

被引：0
|
作者：
del Rosal Rabes, T. [1 ]
Baquero-Artigao, F. [1 ]
Gomez Fernandez, C. [2 ]
Garcia Miguel, M. J. [1 ]
de Lucas Laguna, R. [2 ]
机构：
[1] Hosp Infantil La Paz, Unidad Enfermedades Infecciosas Pediat, Madrid, Spain
[2] Hosp Infantil La Paz, Serv Dermatol Infantil, Madrid, Spain
来源：
ANALES DE PEDIATRIA | 2010年 / 73卷 / 02期
关键词：
BRAZILIENSIS;
D O I：
10.1016/j.anpedi.2010.05.014
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [21] Extensive facial cutaneous leishmaniasis treated successfully with liposomal amphotericin B
    Abualiat, Abdullah
    Alamer, Eman
    Aziz, Tariq
    Eid, Esmat
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB136 - AB136
  • [22] Rapidly progressing facial leishmaniasis: effective treatment with liposomal amphotericin B and a review of the management of Old World cutaneous leishmaniasis
    Islam, Shamim
    PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, 2018, 38 (02) : 158 - 161
  • [23] Early efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis
    Castagnola, E
    Davidson, RN
    Fiore, P
    Tasso, L
    Rossi, G
    Mangraviti, S
    DiMartino, L
    Scotti, S
    Cascio, A
    Pempinello, R
    Gradoni, L
    Giacchino, R
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (03) : 317 - 318
  • [24] Liposomal Amphotericin B drug access for the treatment of leishmaniasis in Brazil
    Mistro, Sostenes
    Rodrigues, Marlon
    Rosa, Lorena
    Camargo, Marianne
    Badaro, Roberto
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2016, 21 (06) : 692 - 693
  • [25] VISCERAL LEISHMANIASIS FOLLOWING TREATMENT WITH LIPOSOMAL AMPHOTERICIN-B
    MCBRIDE, M
    LINNEY, M
    CLAYDON, EJ
    WEBER, J
    CLINICAL INFECTIOUS DISEASES, 1994, 19 (02) : 362 - 362
  • [26] Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients
    Minodier, P
    Retornaz, K
    Horelt, A
    Garnier, JM
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2003, 17 (02) : 183 - 188
  • [27] Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients
    Vigna, E.
    De Vivo, A.
    Gentile, M.
    Morelli, R.
    Lucia, E.
    Mazzone, C.
    Recchia, A. G.
    Vianelli, N.
    Morabito, F.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (05) : 428 - 431
  • [28] Disseminated tegumentary leishmaniasis refractory to liposomal amphotericin B treatment
    Borges, Ana Flavia
    Molina, Juliana D'Andrea
    Milanez Morgado de Abreu, Marilda Aparecida
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2021, 54
  • [29] Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009
    Rosenthal, E.
    Delaunay, P.
    Jeandel, P. -Y.
    Haas, H.
    Pomares-Estran, C.
    Marty, P.
    MEDECINE ET MALADIES INFECTIEUSES, 2009, 39 (10): : 741 - 744
  • [30] Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis
    Kosaka, Atsushi
    Sakamoto, Naoya
    Hikone, Mayu
    Imai, Kazuo
    Ota, Masayuki
    Washino, Takuya
    Maeda, Takuya
    Iwabuchi, Sentarou
    INTERNAL MEDICINE, 2020, 59 (09) : 1227 - 1230
12345